Pharmacokinetics

Half-Life

The time required for the concentration of a compound in a biological system to decrease by half.

Definition

Half-life is a pharmacokinetic parameter that describes the time required for the plasma concentration of a compound to decrease by 50% under defined experimental conditions. It is typically measured in preclinical in vivo models and expressed in minutes, hours, or days depending on the compound class. Half-life is determined by both the rate of metabolic clearance and the volume of distribution, making it a compound-specific but also model-specific value. Researchers use this parameter to design dosing intervals and exposure windows in preclinical study protocols.

Research Context

In peptide research, half-life values vary widely across compound classes: short peptides such as BPC-157 have reported preclinical half-lives of approximately four hours, while longer peptides or those with chemical modifications can exhibit half-lives of several days. Understanding half-life is critical when designing in vivo research protocols to ensure adequate compound exposure throughout the observation window. Most published half-life values for research peptides derive from rodent pharmacokinetic studies.

Relevant Compounds

This term applies to the following research compound hubs.

Frequently Asked Questions

Explore the Research Library

Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.